Lifeward Ltd. (NASDAQ:LFWD) Short Interest Up 18.8% in February

Lifeward Ltd. (NASDAQ:LFWD) was the recipient of a significant increase in short interest in the month of February. As of February 13th, there was short interest totaling 2,351,929 shares, an increase of 18.8% from the January 29th total of 1,979,952 shares. Currently, 13.1% of the shares of the company are sold short. Based on an average daily volume of 241,976 shares, the days-to-cover ratio is currently 9.7 days. Based on an average daily volume of 241,976 shares, the days-to-cover ratio is currently 9.7 days. Currently, 13.1% of the shares of the company are sold short.

Hedge Funds Weigh In On Lifeward

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Jane Street Group LLC increased its position in Lifeward by 77.3% in the 4th quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock valued at $40,000 after acquiring an additional 29,927 shares during the period. Virtu Financial LLC grew its stake in shares of Lifeward by 158.0% in the fourth quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock worth $35,000 after purchasing an additional 37,037 shares in the last quarter. Citadel Advisors LLC increased its holdings in shares of Lifeward by 1,271.8% during the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after purchasing an additional 198,406 shares during the period. Finally, HRT Financial LP raised its stake in shares of Lifeward by 149.7% during the fourth quarter. HRT Financial LP now owns 49,081 shares of the company’s stock valued at $28,000 after purchasing an additional 29,423 shares in the last quarter. 26.76% of the stock is owned by institutional investors.

Analysts Set New Price Targets

LFWD has been the topic of a number of recent research reports. Weiss Ratings restated a “sell (e+)” rating on shares of Lifeward in a research report on Thursday, January 22nd. HC Wainwright cut their target price on shares of Lifeward from $156.00 to $54.00 and set a “buy” rating on the stock in a report on Tuesday, November 18th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $51.00.

Lifeward Stock Down 0.7%

Shares of NASDAQ:LFWD opened at $5.95 on Friday. The company’s 50-day moving average price is $7.05 and its 200 day moving average price is $7.46. The company has a market cap of $9.04 million, a PE ratio of -0.17 and a beta of 0.12. Lifeward has a fifty-two week low of $4.14 and a fifty-two week high of $35.40.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.